11:30AM - 1:00PM ET
Registration Link: https://us02web.zoom.us/meeting/register/tZErdO-hqjsqG9Sf_HldgAKF8qIZhPMsyn9r
Daphne Lainson – Smart & Biggar – Partner & Chair of the Firm
Welcoming everyone & closing the webinar Daphne Lainson is a partner at Smart & Biggar LLP and holds leadership roles as the National Practice Group leader for Life Sciences, and as Chair of the Firm. She is based out of the firm’s Ottawa office. With close to two decades of experience in law and patent agency and an advanced degree in chemistry, Daphne is entrusted by many of the world’s largest innovators to protect inventions across the spectrum of chemical and pharmaceutical innovation. Daphne enthusiastically champions and effectively safeguards her clients’ intellectual property rights relating to new drugs, biologics, medical devices, consumer products, agrochemicals, specialty chemicals, industrial chemical processes, oil, gas and petrochemicals. For her pharmaceutical clients, Daphne is called on for her deep expertise, strategic advice and counseling across the life cycle of a drug, in regards to patents and data protection, including patent listing under the Patented Medicines (Notice of Compliance) Regulations, Certificates of Supplementary Protection, and pricing and reimbursement including Patented Medicine Prices Review Board matters (PMPRB).
Beverley Moore – BLG – Partner & National leader of the IP Litigation Group Moderator
Beverley is national leader of BLG’s Intellectual Property Litigation Group. She practises in all areas of intellectual property litigation, with a focus on complex patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations. Beverley also advises clients on patent portfolio management, including how to navigate IP regulatory issues such as listing patents on the Patent Register, and reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection, and the Register of Innovative Drugs as it relates to data protection. In addition, Beverley advises on patentability, validity, and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada. Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients. Beverley has advocated before the Federal Court and Federal Court of Appeal, as well as the Patented Medicine Prices Review Board. Beverley is one of the co-vice chairs of IPO’s Pharmaceutical and Biotechnology Committee and chairs that group’s Drug Pricing Subcommittee.
Sheema Khan – Kinaxis – Patent Agent Panelist
Sheema Khan is a Patent Agent, currently working at Kinaxis and previously at Stratford Managers Corporation. She holds a B.Sc in Chemistry from McGill, and both an A.M. in Physics and a Ph.D. in Chemical Physics from Harvard. She conducted post-doctoral research at MIT and McGill, before joining a start-up pharmaceutical company, where she was the inventor on a number of patents. She is also a writer for the Globe and Mail and a TEDx speaker. Over the past 20 years, she has drafted patents in many fields, such as pharmaceutical, chemical, biological, mechanical engineering, electrical engineering, business methods, and now AI and machine learning applications. In addition, she is heavily involved in IP strategy.
Judith Robinson – Fineberg Ramamoorthy – Senior Consultant Panelist
Judith Robinson is a senior consultant with Fineberg Ramamoorthy LLP since February 2021, focusing on patent litigation. She has practiced in intellectual property (IP) law before the Federal Courts since she was called to the Barreau du Québec in 1991, when she joined the venerable IP group founded by Joan Clark, Q.C. at Ogilvy Renault (now Norton Rose Fulbright Canada LLP) in Montréal. Judith was a senior partner at the firm, where she was chair of the Canadian IP practice from 2014-2019 and a member of the management committee. Judith has appeared in a variety of IP litigious matters, including cases pursuant to the Patented Medicines (Notice of Compliance) Regulations since their introduction in 1993, as well patent trials, damages /accounting of profits assessments, copyright hearings, judicial review proceedings and related appellate work. A registered trademark agent, Judith is recognized by a number of legal directories. She is a Fellow of the American College of Trial Lawyers.
Alexandra Daoud – Anyon Systems Inc. – Vice President, Intellectual Property and Regulatory Affairs Panelist
Alexandra Daoud is Vice President, Intellectual Property and Regulatory Affairs at Anyon Systems Inc., a leading provider of universal quantum computers based in Dorval, Quebec. She graduated from McGill University in Electrical Engineering and immediately joined Ogilvy Renault (now Norton Rose Fulbright) to begin her intellectual property career, where she spent over 20 years, 13 as a Partner. She is a registered Patent Agent in Canada and in the United States and has been named as a leading practitioner by Who’s Who Legal for 5 consecutive years. Alexandra is a frequent writer and speaker on patent and technology issues, such as patent trolls, software patents and business methods.
THANK YOU TO OUR EVENT HOSTS & SPONSORS
Daphne Lainson – Smart & Biggar Beverley Moore – BLG